Emergent BioSolutions (EBS) Exchange Rate Effect (2010 - 2025)
Emergent BioSolutions (EBS) recorded quarterly Exchange Rate Effect of -$200000.0 in Q3 2025, down 120.0% quarter-over-quarter from $1.0 million in Q2 2025.
Emergent BioSolutions (EBS) Exchange Rate Effect (2010 - 2025) Analysis & Trends
Emergent BioSolutions' Exchange Rate Effect history runs 15 years deep, the most recent figure standing at -$200000.0 for Q3 2025.
- In Q3 2025, Exchange Rate Effect changed N/A year-over-year to -$200000.0; the TTM figure through Mar 2026 stood at $800000.0 (up 214.29% YoY), while the FY2025 annual figure was $100000.0, changed N/A from the prior year.
- Exchange Rate Effect was -$200000.0 for Q3 2025 at Emergent BioSolutions, down from $1.0 million in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $1.1 million in Q4 2022 to a low of -$1.5 million in Q4 2023.
- Historically, Exchange Rate Effect has averaged -$64285.7 across 4 years, with a median of -$200000.0 in 2021.
- The sharpest annual moves came in 2021 and 2022: Exchange Rate Effect tumbled 400.0% in 2021, then jumped 250.0% in 2022.
- A 4-year view of Exchange Rate Effect shows it stood at -$200000.0 in 2021, then surged by 650.0% to $1.1 million in 2022, then slumped by 236.36% to -$1.5 million in 2023, then jumped by 86.67% to -$200000.0 in 2025.
- The last three Exchange Rate Effect figures came in at -$200000.0 (Q3 2025), $1.0 million (Q2 2025), and -$700000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FX Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | -22,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -2.38 Mn |
| 10 | Emergent BioSolutions | 415.46 Mn | 253.96 Mn | 84.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -200,000.00 |
| Sep 30, 2025 | -200,000.00 |
| Jun 30, 2025 | 1.00 Mn |
| Jun 30, 2025 | 1.00 Mn |
| Mar 31, 2025 | -700,000.00 |
| Mar 31, 2025 | -700,000.00 |
| Dec 31, 2023 | -1.50 Mn |
| Dec 31, 2023 | -1.50 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | -600,000.00 |
| Jun 30, 2023 | -600,000.00 |
| Mar 31, 2023 | -200,000.00 |
| Mar 31, 2023 | -200,000.00 |
| Dec 31, 2022 | 1.10 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | -1.00 Mn |
| Sep 30, 2022 | -1.00 Mn |
| Jun 30, 2022 | 700,000.00 |
| Jun 30, 2022 | 700,000.00 |